NCT00355862View on ClinicalTrials.gov

Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

525

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2014

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

CNI, MMF, Steroids, Aza etc. (mTOR inhibitor free)

center specific therapeutic regimen without mTOR inhibition

DRUG

Sirolimus

Sirolimus based immunosuppression

Trial Locations (1)

93053

Regensburg University, Regensburg

All Listed Sponsors
lead

University of Regensburg

OTHER

NCT00355862 - Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter